A retrospective safety study of trifluridine/tipiracil combination tablet (TAS-102) monotherapy in patients with advanced and recurrent colorectal cancer.
Phase of Trial: Phase IV
Latest Information Update: 04 Jul 2016
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 04 Jul 2016 New trial record